Management of Urosepsis

Urosepsis is a life-threatening systemic infection caused by a urinary tract infection (UTI) that progresses to systemic inflammatory response and organ dysfunction. It may develop from infections involving any part of the urinary tract, including cystitis, pyelonephritis, urinary tract obstruction, infected urinary stones, or catheter-associated urinary tract infection (CAUTI).

Urosepsis represents a severe complication of urinary tract infection and requires urgent recognition, antimicrobial therapy, source control, and supportive management to prevent septic shock and death.

The most common causative organisms are similar to those causing urinary tract infections, including Escherichia coli, Klebsiella pneumoniae, Proteus species, Pseudomonas aeruginosa, Enterococcus species, and Staphylococcus aureus. Antimicrobial-resistant organisms are increasingly recognized, particularly among hospitalized patients and those with previous antibiotic exposure or urinary instrumentation.

Epidemiology

Urosepsis accounts for a significant proportion of cases of sepsis worldwide, particularly among elderly patients, individuals with urinary tract abnormalities, and hospitalized patients.

The risk of urosepsis is increased in patients with complicated urinary tract infections, urinary obstruction, urinary catheters, diabetes mellitus, chronic kidney disease, and immunosuppression.

Early recognition and treatment significantly improve outcomes; however, delayed diagnosis may result in septic shock, multi-organ failure, and death.

Risk factors

Urinary tract-related risk factors

• Complicated urinary tract infection

• Acute pyelonephritis

• Urinary tract obstruction

• Urinary stones

• Vesicoureteric reflux

• Neurogenic bladder

• Benign prostatic hyperplasia

• Urinary catheterization

• Recent urinary tract instrumentation

• Congenital urinary tract abnormalities

Patient-related risk factors

• Advanced age

• Diabetes mellitus

• Chronic kidney disease

• Immunosuppression

• Malignancy

• Pregnancy

• Frailty

• Previous recurrent urinary tract infections

• Recent antimicrobial use

• Hospital admission

Pathophysiology

Urosepsis develops when microorganisms from an infected urinary tract enter the bloodstream or trigger an exaggerated systemic inflammatory response.

Bacterial components such as endotoxins stimulate immune cells to release inflammatory mediators, resulting in widespread vasodilation, increased vascular permeability, and impaired tissue perfusion. This causes hypotension, reduced oxygen delivery, and dysfunction of vital organs.

Progressive inflammation may lead to septic shock, characterized by persistent hypotension despite adequate fluid resuscitation and severe circulatory failure. Without prompt treatment, urosepsis can progress to multi-organ dysfunction involving the kidneys, lungs, cardiovascular system, and brain.

Clinical presentation

Urosepsis presents with features of urinary tract infection combined with systemic manifestations of infection and organ dysfunction.

Symptoms

Symptoms may include:

• Fever or chills

• Flank pain

• Dysuria

• Urinary frequency

• Urinary urgency

• Suprapubic discomfort

• Nausea and vomiting

• General weakness

• Reduced urine output

• Confusion or altered mental status

• Shortness of breath

• Dizziness or fainting

Clinical signs

Features suggesting urosepsis include:

Infection-related signs

• Temperature >38°C or <36°C

• Tachycardia (>90 beats/minute)

• Tachypnoea (>20 breaths/minute)

• Flank tenderness

• Suprapubic tenderness

Organ dysfunction signs

• Confusion or altered consciousness

• Hypotension

• Reduced urine output

• Acute kidney injury

• Increased respiratory rate

• Low oxygen saturation

• Elevated lactate levels

• Signs of poor peripheral perfusion

Diagnostic criteria

Urosepsis should be suspected in patients with urinary tract infection features accompanied by systemic inflammatory response and organ dysfunction.

Clinical features supporting diagnosis include:

• Evidence of urinary tract infection

• Presence of systemic infection signs

• Evidence of organ dysfunction

Systemic features may include:

• Temperature >38°C or <36°C

• Heart rate >90 beats/minute

• Respiratory rate >20 breaths/minute

• White blood cell count >12,000/mm³ or <4,000/mm³

Organ dysfunction may include:

• Hypotension

• Altered mental status

• Acute kidney injury

• Respiratory failure

• Coagulopathy

• Elevated lactate levels

Investigations

Investigations should be performed urgently while antimicrobial therapy is initiated without unnecessary delay.

Urine investigations

• Urinalysis

  • Leukocyte esterase

  • Nitrites

  • Protein

  • Blood

• Urine microscopy

  • White blood cells

  • Bacteria

  • Casts

• Quantitative urine culture and antimicrobial susceptibility testing

Blood investigations

• Blood cultures before antimicrobial administration where possible

• Full blood count

• Serum creatinine

• Blood urea nitrogen

• Serum electrolytes

• Blood glucose

• Liver function tests

• C-reactive protein

• Serum lactate

• Coagulation profile

Imaging investigations

Imaging is important to identify the source of infection and obstruction.

Investigations include:

• Ultrasound of kidneys and urinary tract

• Kidney, ureter, and bladder imaging where indicated

• CT scan of urinary tract when obstruction, stones, abscess, or complications are suspected

Additional investigations

• Arterial blood gas analysis in severe cases

• Chest radiograph if respiratory complications are suspected

• ECG monitoring in patients with electrolyte abnormalities or shock

Management

Urosepsis is a medical emergency requiring urgent antimicrobial therapy, haemodynamic stabilization, identification of the source of infection, and management of underlying urinary tract abnormalities.

Management includes:

• Early recognition of sepsis.

• Collection of urine and blood cultures before antibiotics where possible.

• Immediate initiation of empirical antimicrobial therapy.

• Fluid resuscitation and supportive care.

• Correction of urinary obstruction or removal of infected devices where indicated.

• Adjustment of antimicrobial therapy according to culture results.

Non-pharmacological treatment

• Assess airway, breathing, and circulation.

• Monitor vital signs closely.

• Establish intravenous access.

• Ensure adequate hydration and maintain tissue perfusion.

• Monitor urine output.

• Provide oxygen therapy when indicated.

• Manage complications such as shock, electrolyte abnormalities, and acute kidney injury.

• Identify and control the source of infection, including urinary obstruction or infected catheters.

Pharmacological treatment

First-line treatment

• Gentamicin 120 mg intravenously or intramuscularly once daily for 5 days.

Children:

• Gentamicin 7.5 mg/kg intravenously or intramuscularly once daily for 5 days.

Completion of a 10-day antimicrobial course should be guided by urine and blood culture results.

AND

• Ceftriaxone + sulbactam (fixed-dose combination) 1 g intravenously every 24 hours for 5 days.

Children:

• Ceftriaxone 80 mg/kg intravenously or intramuscularly every 24 hours for 5 days.

Alternative treatment

• Gentamicin 120 mg intravenously or intramuscularly once daily for 5 days.

Children:

• Gentamicin 7.5 mg/kg intravenously or intramuscularly once daily for 5 days.

AND

• Piperacillin + tazobactam (fixed-dose combination) 4.5 g intravenously every 6–8 hours for 5–7 days.

OR

• Meropenem 250–500 mg intravenously every 8 hours for 5–7 days.

Once urine and blood culture results become available, antimicrobial therapy should be modified according to the identified organism and antimicrobial susceptibility pattern.

Management according to underlying cause

Acute pyelonephritis

• Treat with appropriate antimicrobial therapy.

• Monitor renal function.

• Assess for complications.

Urinary tract obstruction

• Emergency relief of obstruction is required.

• Urological intervention may include:

  • Ureteric stenting

  • Percutaneous nephrostomy

Infected urinary stones

• Treat infection urgently.

• Drain infected obstructed systems.

• Definitive stone management after stabilization.

Catheter-associated infection

• Remove unnecessary catheter.

• Replace catheter if continued drainage is required.

• Obtain cultures before antimicrobial adjustment.

Prostatic obstruction

• Manage urinary retention.

• Refer for urological assessment.

Referral

Urgent referral is required for:

• Septic shock

• Persistent hypotension

• Altered mental status

• Acute kidney injury

• Respiratory failure

• Need for vasopressor support

• Urinary obstruction requiring intervention

• Renal abscess

• Failure of initial treatment

• Multidrug-resistant infection

• Need for intensive care management

Complications

• Septic shock

• Multi-organ dysfunction syndrome

• Acute kidney injury

• Acute respiratory distress syndrome

• Disseminated intravascular coagulation

• Renal abscess

• Perinephric abscess

• Chronic kidney disease

• Prolonged hospitalization

• Death

Prognosis

The prognosis depends on the severity of infection, timing of treatment, patient comorbidities, and presence of organ dysfunction.

Early administration of effective antimicrobial therapy and rapid control of the infection source significantly improve outcomes. Patients with septic shock, advanced age, chronic kidney disease, or delayed treatment have higher mortality risk.

Prevention

• Early diagnosis and treatment of urinary tract infections

• Appropriate antimicrobial use

• Avoid unnecessary urinary catheterization

• Early removal of urinary catheters

• Proper catheter care

• Prompt treatment of urinary obstruction

• Management of urinary stones

• Control of diabetes mellitus

• Regular follow-up for patients with recurrent UTIs

• Infection prevention measures in healthcare facilities